EUVIMEDEUVIMED entdecken
Crossref

Aptamer‐modified tetrahedral DNA nanostructure‐immobilized liposome for specific gene delivery and potential cancer theragnostic

Doo Young Lim, Byeong Hee Hwang iD

Biotechnology Journal · 2024

DOI: 10.1002/biot.202300156 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology Journal, 2024. Verfasst von Doo Young Lim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering and Nano-bioengineering, Incheon National University, Incheon, South Korea. Hauptthemen laut MEDLINE: Aptamers, Nucleotide, Nanostructures, Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Ministry of Science, ICT and Future Planning, Incheon National University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeted delivery of therapeutic agents to cancer cells is crucial for effective cancer treatment without adverse effects. In this study, we developed a novel delivery carrier, Aptamer‐modified tetrahedral DNA nanostructure (TDN) immobilized Liposome (ApTL), for specific delivery to nucleolin‐overexpressing cancer cells. We demonstrated that targeted ApTL was highly effective in delivering plasmid and mRNA to nucleolin‐overexpressing cancer cells compared to non‐targeted ApTL with a non‐specific aptamer. ApTL, which is highly negative and nano‐sized, specifically delivered nucleic acids to MDA‐MB‐231 and HeLa cancer cells, primarily via lipid‐raft‐mediated endocytosis. Furthermore, the co‐delivery of mRNA and doxorubicin resulted in increased apoptosis and reduced cancer cell viability. Interestingly, co‐delivery of mRNA and Dox did not show a significant difference in EGFP expression at 24 h but dramatically increased EGFP expression at 48 h, making ApTL/mEGFP/Dox a promising candidate for detecting live cancer cells after targeted cancer drug treatment. Our results suggest that ApTL can be a promising tool for the targeted delivery of therapeutic agents to nucleolin‐overexpressing cancer cells, providing a new strategy for cancer theragnostic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aptamers, NucleotideNanostructuresNeoplasmsHumansLiposomesDrug Delivery SystemsDoxorubicinDNARNA, MessengerCell Line, Tumor

Stichwörter der Autor:innen

aptamercancer therapymRNA deliverynanotechnologytargeted drug deliverytherapeutics

Substanzen

LiposomesAptamers, NucleotideDoxorubicinDNARNA, Messenger

Autor:innen und Institutionen

  • Department of Bioengineering and Nano-bioengineering, Incheon National University, Incheon, South Korea.
  • Division of Bioengineering, Incheon National University, Incheon, South Korea.
  • Research Center for Bio Material & Process Development, Incheon National University, Incheon, Republic of Korea.
  • Institute for New Drug Development, Incheon National University, Incheon, South Korea.

ORCID-Profile: Byeong Hee Hwang

Förderung

  • Ministry of Science, ICT and Future Planning
  • Incheon National University

Zitieren

APA

Lim, D. Y., & Hwang, B. H. (2024). Aptamer‐modified tetrahedral DNA nanostructure‐immobilized liposome for specific gene delivery and potential cancer theragnostic. Biotechnology Journal. https://doi.org/10.1002/biot.202300156

Vancouver

Lim DY, Hwang BH. Aptamer‐modified tetrahedral DNA nanostructure‐immobilized liposome for specific gene delivery and potential cancer theragnostic. Biotechnology Journal. 2024. doi:10.1002/biot.202300156

BibTeX
@article{Lim2024,
  author = {Lim, Doo Young and Hwang, Byeong Hee},
  title = {Aptamer‐modified tetrahedral DNA nanostructure‐immobilized liposome for specific gene delivery and potential cancer theragnostic},
  journal = {Biotechnology Journal},
  year = {2024},
  doi = {10.1002/biot.202300156}
}
Kostenlos starten →